PHILADELPHIA, June 24, 2019 /PRNewswire/ -- Enterin Inc., a CNS pharmaceutical company based in Philadelphia and developing novel compounds to treat Parkinson's disease (PD), has enrolled the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results